Medical Care Technologies (MDCE) Ratios

17 Followers

Medical Care Technologies Ratios

MDCE's free cash flow for Q4 2025 was $2.24. For the 2025 fiscal year, MDCE's free cash flow was decreased by $ and operating cash flow was $1.69. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23
Liquidity Ratios
Current Ratio	70.69	70.69	17.87	8.69
Quick Ratio	18.44	18.44	1.82	8.69
Cash Ratio	10.42	10.42	0.64	0.51
Solvency Ratio	8.65	8.65	1.83	-0.09
Operating Cash Flow Ratio	7.30	5.83	-7.51	0.43
Short-Term Operating Cash Flow Coverage	19.49	15.55	-9.10	0.76
Net Current Asset Value	$ 1.86M	$ 1.86M	$ 1.38M	$ 533.98K
Leverage Ratios
Debt-to-Assets Ratio	<0.01	<0.01	0.05	0.06
Debt-to-Equity Ratio	<0.01	<0.01	0.05	0.07
Debt-to-Capital Ratio	<0.01	<0.01	0.05	0.07
Long-Term Debt-to-Capital Ratio	0.00	0.00	0.00	0.00
Financial Leverage Ratio	1.01	1.01	1.06	1.13
Debt Service Coverage Ratio	13.74	13.74	2.18	0.00
Interest Coverage Ratio	32.49	32.49	58.70	-58.75
Debt to Market Cap	<0.01	<0.01	0.01	<0.01
Interest Debt Per Share	<0.01	<0.01	<0.01	<0.01
Net Debt to EBITDA	-1.13	-1.13	0.10	0.00
Profitability Margins
Gross Profit Margin	53.76%	53.75%	49.03%	-7.82%
EBIT Margin	22.21%	22.21%	23.31%	-52.05%
EBITDA Margin	22.21%	22.21%	23.31%	0.00%
Operating Profit Margin	22.21%	22.21%	23.31%	-52.05%
Pretax Profit Margin	21.53%	21.53%	22.91%	-52.94%
Net Profit Margin	21.53%	21.53%	22.91%	-52.94%
Continuous Operations Profit Margin	21.53%	21.53%	22.91%	-52.94%
Net Income Per EBT	100.00%	100.00%	100.00%	100.00%
EBT Per EBIT	96.94%	96.93%	98.30%	101.70%
Return on Assets (ROA)	12.24%	12.24%	10.26%	-64.21%
Return on Equity (ROE)	15.53%	12.41%	10.87%	-72.57%
Return on Capital Employed (ROCE)	12.80%	12.80%	11.06%	-71.35%
Return on Invested Capital (ROIC)	12.74%	12.74%	10.54%	-66.48%
Return on Tangible Assets	12.24%	12.24%	10.26%	-64.21%
Earnings Yield	23.57%	17.75%	2.46%	-6.00%
Efficiency Ratios
Receivables Turnover	0.00	0.00	0.00	0.00
Payables Turnover	0.00	0.00	0.00	0.00
Inventory Turnover	0.36	0.36	0.25	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00
Asset Turnover	0.57	0.57	0.45	1.21
Working Capital Turnover Ratio	0.65	0.66	0.68	1.01
Cash Conversion Cycle	1.03K	1.03K	1.44K	0.00
Days of Sales Outstanding	0.00	0.00	0.00	0.00
Days of Inventory Outstanding	1.03K	1.03K	1.44K	0.00
Days of Payables Outstanding	0.00	0.00	0.00	0.00
Operating Cycle	1.03K	1.03K	1.44K	0.00
Cash Flow Ratios
Operating Cash Flow Per Share	<0.01	<0.01	>-0.01	<0.01
Free Cash Flow Per Share	<0.01	<0.01	>-0.01	<0.01
CapEx Per Share	<0.01	0.00	0.00	0.00
Free Cash Flow to Operating Cash Flow	1.00	1.00	1.00	1.00
Dividend Paid and CapEx Coverage Ratio	194.88K	0.00	0.00	0.00
Capital Expenditure Coverage Ratio	194.88K	0.00	0.00	0.00
Operating Cash Flow Coverage Ratio	19.49	15.55	-9.10	0.76
Operating Cash Flow to Sales Ratio	0.18	0.15	-0.94	0.04
Free Cash Flow Yield	17.63%	11.96%	-10.06%	0.46%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	4.24	5.63	40.72	-16.67
Price-to-Sales (P/S) Ratio	1.03	1.21	9.33	8.82
Price-to-Book (P/B) Ratio	0.53	0.70	4.43	12.09
Price-to-Free Cash Flow (P/FCF) Ratio	5.67	8.36	-9.94	215.92
Price-to-Operating Cash Flow Ratio	5.02	8.36	-9.94	215.91
Price-to-Earnings Growth (PEG) Ratio	0.04	0.00	-0.41	0.12
Price-to-Fair Value	0.53	0.70	4.43	12.09
Enterprise Value Multiple	3.52	4.34	40.12	0.00
Enterprise Value	837.43K	1.03M	6.14M	6.46M
EV to EBITDA	3.52	4.34	40.12	0.00
EV to Sales	0.78	0.96	9.35	8.83
EV to Free Cash Flow	4.30	6.64	-9.96	216.05
EV to Operating Cash Flow	4.30	6.64	-9.96	216.04
Tangible Book Value Per Share	<0.01	<0.01	<0.01	<0.01
Shareholders’ Equity Per Share	<0.01	<0.01	<0.01	<0.01
Tax and Other Ratios
Effective Tax Rate	0.00	0.00	0.00	0.00
Revenue Per Share	<0.01	<0.01	<0.01	<0.01
Net Income Per Share	<0.01	<0.01	<0.01	>-0.01
Tax Burden	1.00	1.00	1.00	1.00
Interest Burden	0.97	0.97	0.98	1.02
Research & Development to Revenue	0.00	0.00	0.00	0.00
SG&A to Revenue	0.32	0.32	0.26	0.44
Stock-Based Compensation to Revenue	0.00	0.00	0.00	0.00
Income Quality	0.51	0.67	-4.10	-0.08

Currency in USD